| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
430 |
| issn |
1534-3170
1523-3782 |
| issueIdentifier |
5 |
| pageRange |
424-430 |
| publicationName |
Current Cardiology Reports |
| startingPage |
424 |
| bibliographicCitation |
Tamhane UU, Gurm HS. GP IIb/IIIa inhibitors during primary percutaneous coronary intervention for STEMI: new trial and registry data. Curr Cardiol Rep. 2008 Sep;10(5):424–30. doi: 10.1007/s11886-008-0066-5. PMID: 18715540. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cb1e96e668803fa1e11240314545e90
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f718a6f3553dd89edb36aa979cea3a57 |
| date |
200809 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/18715540
https://doi.org/10.1007/s11886-008-0066-5 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21832
https://portal.issn.org/resource/ISSN/1523-3782
https://portal.issn.org/resource/ISSN/1534-3170 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
GP IIb/IIIa inhibitors during primary percutaneous coronary intervention for STEMI: New trial and registry data |
| discusses |
http://id.nlm.nih.gov/mesh/M0028424 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448812
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6592
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9b21d1a174c364b6f99c6662d34d6034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 |